FOXO4-DRI is an advanced senolytic peptide designed to support healthy aging by targeting senescent ("aged" or dysfunctional) cells that gradually accumulate over time. These cells can contribute to chronic low-grade inflammation, impaired tissue regeneration, reduced metabolic efficiency, and age-related decline in physical performance. FOXO4-DRI has been investigated for its ability to selectively promote the clearance of senescent cells while preserving healthy cells, helping maintain a healthier cellular environment. By supporting natural cellular renewal, FOXO4-DRI may contribute to improved tissue regeneration, metabolic health, muscle recovery, cognitive wellness, and overall vitality. It is increasingly explored within longevity-focused wellness protocols and regenerative health strategies under professional supervision. FOXO4-DRI is designed to interfere with the interaction between the FOXO4 protein and p53 within senescent cells. This interaction helps dysfunctional cells survive despite being damaged. By disrupting this pathway, FOXO4-DRI may encourage the natural removal of senescent cells through apoptosis while leaving healthy cells largely unaffected. Reducing the burden of senescent cells may help support healthier tissue remodeling, balanced inflammatory signaling, improved cellular communication, enhanced regenerative capacity, and better overall physiological function associated with healthy aging. FOXO4-DRI is commonly incorporated into professionally supervised wellness and longevity protocols for: Dosage should always be individualized according to treatment goals and administered under the supervision of a qualified healthcare professional. Typical research and wellness protocols often utilize 250–500 mcg daily for 5–10 consecutive days, followed by an appropriate off-cycle period based on professional guidance. Store the lyophilized vial at 2–8°C, protected from heat, moisture, and direct sunlight. After reconstitution, refrigerate immediately, avoid freezing, and use aseptic injection techniques during preparation and administration. FOXO4-DRI is generally well tolerated when administered appropriately under professional supervision. Some individuals may experience mild injection-site irritation, temporary fatigue, headache, nausea, muscle soreness, or transient flu-like symptoms during periods of increased cellular clearance. If severe or persistent adverse effects occur, discontinue use and consult a healthcare professional. FOXO4-DRI should only be used under the supervision of a qualified healthcare professional. Individuals with active malignancy, autoimmune disorders, chronic medical conditions, or those undergoing immunosuppressive therapy should consult their physician before use. It is not recommended during pregnancy or breastfeeding. Routine medical monitoring is recommended during extended longevity protocols. FOXO4-DRI is commonly incorporated into comprehensive longevity and regenerative wellness protocols. Depending on individual goals, it may be combined under professional supervision with mitochondrial-support peptides, NAD+ therapies, regenerative peptides, metabolic optimization compounds, or recovery-focused protocols to support overall cellular health and healthy aging. The information provided is for educational purposes only and is not intended as medical advice. Use FOXO4-DRI only under the supervision of a qualified healthcare professional. Product images are for illustration purposes only and may differ from the actual product. Packaging, formulation, and labeling are subject to change without prior notice.FOXO4-DRI
FOXO4-DRI: Advanced Senolytic Peptide for Healthy Aging & Cellular Rejuvenation
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer